Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacira Pharm Inc (NQ: PCRX )

29.23 -0.63 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 826,221
Open 29.78
Bid (Size) 11.71 (2)
Ask (Size) 45.00 (7)
Prev. Close 29.86
Today's Range 28.54 - 29.78
52wk Range 28.54 - 58.10
Shares Outstanding 44,454,792
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Announces Leadership Succession Plan
From Pacira BioSciences
Via GlobeNewswire

Performance

YTD
-24.78%
-24.78%
1 Month
-15.91%
-15.91%
3 Month
-27.09%
-27.09%
6 Month
-29.34%
-29.34%
1 Year
-46.92%
-46.92%

More News

Read More
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
From Pacira BioSciences
Via GlobeNewswire
4 Analysts Have This to Say About Pacira BioSciences
Via Benzinga
Analyst Ratings for Pacira BioSciences
Via Benzinga
Looking Into Pacira BioSciences's Return On Capital Employed
Via Benzinga
Recap: Pacira BioSciences Q1 Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Pacira BioSciences Reports Second Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Why Pacira BioSciences Shares Are Trading Lower Today
Via Benzinga
Pacira BioSciences Reports First Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
From Pacira BioSciences
Via GlobeNewswire
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
From Pacira BioSciences
Via GlobeNewswire
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
From Pacira BioSciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.